Biologics, Small Molecules, OTC
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
37
NCT04485546
Study to Evaluate OXERVATE™ in Patients With Stage 1 Neurotrophic Keratitis
Phase: Phase 4
Role: Collaborator
Start: Sep 9, 2020
Completion: Mar 30, 2022
Loading map...